Published • loading... • Updated
Nine in 10 deaf children ‘hear for the first time’ in otoferlin gene therapy trial
Summary by Liam O'Dell
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Nine in 10 deaf children ‘hear for the first time’ in otoferlin gene therapy trial
A gene therapy known as DB-OTO enabled 92 per cent of trial participants to achieve “clinically meaningful hearing improvement” – according to results shared at the World Congress on Audiology in South Korea on Wednesday.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
